The current stock price for Aptose Biosciences Inc. (APTO) is $0.44. The stock experienced a significant increase during the last trading session, reaching $0.4643 after opening at $0.4617. It dipped to a low of $0.421 before ultimately closing at $0.48.
The market performance of Aptose Biosciences Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $1.05 on 06/01/22, with the lowest value for the same timeframe being $0.43, recorded on 05/24/23.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
52-week price history of APTO Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Aptose Biosciences Inc.’s current trading price is -58.29% away from its 52-week high, while its distance from the 52-week low is 2.94%. The stock’s price range during this period has fluctuated between $0.43 and $1.05. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.98 million for the day, which was evidently higher than the average daily volume of 0.19 million over the last three months.
Financial Performance and Market Capitalization
Aptose Biosciences Inc. (APTO) has experienced a quarterly decline of -33.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 42.57M and boasts a workforce of 35 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5948, with a change in price of -0.1010. Similarly, Aptose Biosciences Inc. recorded 206,612 in trading volume during the last 100 days, posting a change of -18.74%.
APTO Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for APTO stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
APTO Stock Stochastic Average
The raw stochastic average for Aptose Biosciences Inc. over the last 50 days is presently at 6.69%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 10.69%. Further, the company’s Stochastic %K and %D values for the last 20 days were 10.74% and 9.58%, respectively.
APTO Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -24.48% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -32.09%. Over the past 30 days, the price of APTO has leaped by -8.75%. And in the last five days, it has fallen by -8.31%.
